Minghui Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 22
- RNA modifications and cancer 11
- Advanced biosensing and bioanalysis techniques 9
-
- MicroRNA in disease regulation 20
- Cancer-related molecular mechanisms research 20
- Cancer Genomics and Diagnostics 14
- Co-authors
- Erwei Song (5 shared papers)Herui Yao (3 shared papers)Duoguang Wu (26 shared papers)Xiaotian He (14 shared papers)Nengtai Ouyang (2 shared papers)Balázs Antus (1 shared paper)Markus Hörbelt (1 shared paper)Michael S. Exton (1 shared paper)
- Journals
- Frontiers in Pharmacology (4 papers)PLoS ONE (3 papers)Hepatology International (2 papers)Advanced Healthcare Materials (2 papers)Cancer Letters (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Minghui Wang
129 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.4k
- Oncology 1.0k
- Molecular Biology 2.2k
- Immunology 521
- Pulmonary and Respiratory Medicine 599
Countries citing papers authored by Minghui Wang
This map shows the geographic impact of Minghui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minghui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minghui Wang more than expected).
Fields of papers citing papers by Minghui Wang
This network shows the impact of papers produced by Minghui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minghui Wang. The network helps show where Minghui Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Minghui Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness Hit paper breakdown → | 2018 | 921 |
| 2 | 2000 | 357 | |
| 3 | 2013 | 140 | |
| 4 | 2019 | 139 | |
| 5 | 2013 | 101 | |
| 6 | 2017 | 100 | |
| 7 | 2019 | 90 | |
| 8 | 2019 | 89 | |
| 9 | 2023 | 87 | |
| 10 | 2019 | 69 | |
| 11 | 2020 | 63 | |
| 12 | 2017 | 51 | |
| 13 | 2019 | 49 | |
| 14 | 2019 | 49 | |
| 15 | 2011 | 49 | |
| 16 | 2022 | 48 | |
| 17 | 1997 | 47 | |
| 18 | 2020 | 44 | |
| 19 | LncRNA MEG3-derived miR-361-5p regulate vascular smooth muscle cells proliferation and apoptosis by targeting ABCA1. | 2019 | 44 |
| 20 | 2019 | 41 |
About Minghui Wang
Minghui Wang is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 137 papers that have together received 3.9k indexed citations. Recurring topics across this work include Circular RNAs in diseases (22 papers), MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (20 papers), Cancer Genomics and Diagnostics (14 papers), RNA modifications and cancer (11 papers), Esophageal Cancer Research and Treatment (9 papers), Advanced biosensing and bioanalysis techniques (9 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.0k citations), Molecular Biology (2.2k citations), Immunology (521 citations) and Pulmonary and Respiratory Medicine (599 citations). Minghui Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Erwei Song, Herui Yao, Duoguang Wu, Xiaotian He, Nengtai Ouyang, Balázs Antus, Markus Hörbelt, Michael S. Exton, Xueting Hu and Jiang Liu. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, Hepatology International, Advanced Healthcare Materials and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.